News archive

The 24th Congress of the International Society for Aerosols in Medicine (ISAM) will be held Aug. 26-30, 2023, in Saarbrücken, Germany. The conference will focus on drug delivery in pulmonary medicine. It will bring together leading scientists in aerosol and drug therapy from academia, industry, hospitals, regulatory agencies, and other healthcare professionals.

Animal-free methods can measure whether a chemical irreversibly damages the eye or does not damage it. However, until now it was not possible to reliably distinguish between irreversible and reversible damage to the eye. Researchers at the Fraunhofer Institute ISC are taking steps to remedy this situation.

This year, Berlin Animal Welfare Prizes will again be awarded. Berlin's State Animal Welfare Officer Dr. Kathrin Herrmann is asking Berliners for suggestions.

Using lung cell culture experiments, scientists at ETH Zurich led by Prof. Shana Sturla have shown which DNA units are altered by benzo(a)pyrene metabolites and where, and thus can trigger lung cancer in the long term.

The Hertie Institute for Artificial Intelligence in Brain Health (Hertie AI), which was founded on February 1 at the Medical Faculty of the University of Tübingen, is the first institute in Germany to conduct research into the prevention and early diagnosis of diseases of the nervous system using methods of artificial intelligence.

Among the ten funded projects, some human 3D models and in silico methods will also be funded.

Researchers at the Swiss Federal Institute of Technology Zurich, led by Professor Andreas Hierlemann, have developed a microfluidic 3D blood-brain barrier model that can be used to better investigate, for example, therapies against brain tumors.

The European Directorate for the Quality of Medicines (EDQM) has published 59 amended texts in the European Pharmacopoeia (Ph. Eur.) concerning the rabbit pyrogenicity test for public consultation. The goal is to replace the rabbit test with an in vitro alternative.

A team of researchers from the Helmholtz Institute for Pharmaceutical Research at Saarland University (HIPS), led by Prof. Claus-Michael Lehr has developed a new human lung cell line for drug testing and disease model development.

The 3Rs Centre Utrecht launches a campaign on social media, aimed at researchers who work with Fetal Calf Serum (FCS).